The strategic appointment is also critical to reinforcing Healthium’s market leadership, corporate governance and deep domain expertis
The partnership will capitalize on the combined capabilities of the two organizations
The appointment is effective from May 01, 2023 for five years
The YP-P10 pre-clinical head-to-head study, jointly conducted by five people including Dr. Kyungho Park of Naason Science
Cipla has recently signed an agreement to make and market the diabetes therapy Galvus and its combination brands in India from 01 January 2026.
New high-tech facility in Biberach offers attractive workplaces for more than 500 scientists
The burden of treating chronic wounds is growing rapidly due to increasing health care costs
Aji Bio-Pharma has six fill finish lines located in San Diego, including a new line
SÜDPACK is setting standards in terms of both performance and sustainability
Subscribe To Our Newsletter & Stay Updated
